133 related articles for article (PubMed ID: 20398057)
1. Clinicopathological significance of nuclear factor-kappa B, HIF-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancer.
Kwon HC; Kim SH; Oh SY; Lee S; Kwon KA; Lee JH; Choi HJ; Park KJ; Lee HS; Roh MS; Kim HJ
Cancer Sci; 2010 Jun; 101(6):1557-61. PubMed ID: 20398057
[TBL] [Abstract][Full Text] [Related]
2. AEG-1 Contributes to Metastasis in Hypoxia-Related Ovarian Cancer by Modulating the HIF-1alpha/NF-kappaB/VEGF Pathway.
Yu X; Wang Y; Qiu H; Song H; Feng D; Jiang Y; Deng S; Meng H; Geng J
Biomed Res Int; 2018; 2018():3145689. PubMed ID: 29770329
[TBL] [Abstract][Full Text] [Related]
3. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
[TBL] [Abstract][Full Text] [Related]
4. Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications.
Cao D; Hou M; Guan YS; Jiang M; Yang Y; Gou HF
BMC Cancer; 2009 Dec; 9():432. PubMed ID: 20003271
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of hypoxia-inducible factor 1α, and its correlation with p53 and vascular endothelial growth factor expression in resectable esophageal squamous cell carcinoma.
Shao N; Han Y; Song L; Song W
J Cancer Res Ther; 2020; 16(2):269-275. PubMed ID: 32474512
[TBL] [Abstract][Full Text] [Related]
6. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis.
Nam SY; Ko YS; Jung J; Yoon J; Kim YH; Choi YJ; Park JW; Chang MS; Kim WH; Lee BL
Br J Cancer; 2011 Jan; 104(1):166-74. PubMed ID: 21119667
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic significance of nuclear factor-κB and vascular endothelial growth factor expression in advanced gastric cancer patients.
Park KW; Kim SJ; Oh SY
Oncol Res Treat; 2014; 37(4):183-90. PubMed ID: 24732642
[TBL] [Abstract][Full Text] [Related]
8. Roles of HIF-1α, VEGF, and NF-κB in Ischemic Preconditioning-Mediated Neuroprotection of Hippocampal CA1 Pyramidal Neurons Against a Subsequent Transient Cerebral Ischemia.
Lee JC; Tae HJ; Kim IH; Cho JH; Lee TK; Park JH; Ahn JH; Choi SY; Bai HC; Shin BN; Cho GS; Kim DW; Kang IJ; Kwon YG; Kim YM; Won MH; Bae EJ
Mol Neurobiol; 2017 Nov; 54(9):6984-6998. PubMed ID: 27785755
[TBL] [Abstract][Full Text] [Related]
9. [Relationship of hypoxia-inducible factor 1 alpha (HIF-1alpha) gene expression with vascular endothelial growth factor (VEGF) and microvessel density (MVD) in human colorectal adenoma and adenocarcinoma].
Jiang CQ; Liu ZS; Qian Q; He YM; Yuan YF; Ai ZL
Ai Zheng; 2003 Nov; 22(11):1170-4. PubMed ID: 14613646
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma.
Ma J; Zhang L; Ru GQ; Zhao ZS; Xu WJ
World J Gastroenterol; 2007 Mar; 13(11):1680-6. PubMed ID: 17461470
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP
World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256
[TBL] [Abstract][Full Text] [Related]
12. Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.
Riddell JR; Maier P; Sass SN; Moser MT; Foster BA; Gollnick SO
PLoS One; 2012; 7(11):e50394. PubMed ID: 23185615
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases.
Shimomura M; Hinoi T; Kuroda S; Adachi T; Kawaguchi Y; Sasada T; Takakura Y; Egi H; Okajima M; Tashiro H; Nishizaka T; Ohdan H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S527-36. PubMed ID: 23748663
[TBL] [Abstract][Full Text] [Related]
14. Dihydroartemisinin Increases the Sensitivity of Photodynamic Therapy Via NF-κB/HIF-1α/VEGF Pathway in Esophageal Cancer Cell in vitro and in vivo.
Li Y; Sui H; Jiang C; Li S; Han Y; Huang P; Du X; Du J; Bai Y
Cell Physiol Biochem; 2018; 48(5):2035-2045. PubMed ID: 30099443
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia and P. gingivalis synergistically induce HIF-1 and NF-κB activation in PDL cells and periodontal diseases.
Gölz L; Memmert S; Rath-Deschner B; Jäger A; Appel T; Baumgarten G; Götz W; Frede S
Mediators Inflamm; 2015; 2015():438085. PubMed ID: 25861162
[TBL] [Abstract][Full Text] [Related]
16. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
Wu W; Pan C; Yu H; Gong H; Wang Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
[TBL] [Abstract][Full Text] [Related]
18. The correlation between HIF-1 alpha and VEGF in oral squamous cell carcinomas: Expression patterns and quantitative immunohistochemical analysis.
Lee LT; Wong YK; Chan MY; Chang KW; Chen SC; Chang CT; Wang J
J Chin Med Assoc; 2018 Apr; 81(4):370-375. PubMed ID: 29289482
[TBL] [Abstract][Full Text] [Related]
19. Activation of NF-κB signaling pathway during HCG-induced VEGF expression in luteal cells.
Zhang Z; Huang Y; Zhang J; Liu Z; Lin Q; Wang Z
Cell Biol Int; 2019 Mar; 43(3):344-349. PubMed ID: 30597662
[TBL] [Abstract][Full Text] [Related]
20. The prognostic role of HIF-1α and NF-κB expression in RAS wild-type metastatic colorectal cancer: A Turkish Oncology Group (TOG) study.
Demirkıran A; Kılınç F; Koçak MZ; Demirkıran D; Korkmaz M; Eryılmaz MK; Araz M; Karaağaç M; Artaç M
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6849-6856. PubMed ID: 36808300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
